Low cholesterol may cut risk for high-grade prostate cancer
November 4th, 2009 - 4:17 pm ICT by ANI ( Leave a comment )Washington, Nov 4 (ANI): Men with low cholesterol levels are less likely to suffer from aggressive form of prostate cancer, say researchers.
The study led by Johns Hopkins researchers showed that having lower levels of heart-clogging fat might cut a man’s risk of high grade prostate cancer by nearly 60 percent.
“For many reasons, we know that it’s good to have a cholesterol level within the normal range,” said Elizabeth Platz, Sc.D., M.P.H., associate professor at the Johns Hopkins Bloomberg School of Public Health and co-director of the cancer prevention and control program at the Johns Hopkins Kimmel Cancer Centre.
“Now, we have more evidence that among the benefits of low cholesterol may be a lower risk for potentially deadly prostate cancers,” she added.
During the study, researchers analyzed data from 5,586 men aged 55 and older enrolled in the Prostate Cancer Prevention Trial from 1993 to 1996. Some 1,251 men were diagnosed with prostate cancer during the study period.
They found that men with cholesterol levels lower than 200 mg/dL had a 59 percent lower risk of developing high-grade prostate cancers, which tend to grow and spread rapidly.
Cholesterol levels had no significant effect on the entire spectrum of prostate cancer incidence, only those that were high-grade, said Platz.
However, Platz cautions that, while the group took into account factors that could bias the results, such as smoking history, weight, family history of prostate cancer, and dietary cholesterol, other things could have affected their results. One example is whether men in the study were taking cholesterol-lowering drugs at the time of the blood collections, a data point the researchers expect to analyze soon.
“Cholesterol may affect cancer cells at a level where it influences key signaling pathways controlling cell survival. Cancer cells use these survival pathways to evade the normal cycle of cell life and death,” said Platz.
The study appears in the journal Cancer Epidemiology, Biomarkers and Prevention. (ANI)
- Cardiac drug, digoxin, could lower risk for prostate cancer - Apr 04, 2011
- Omega-3 fatty acids good for heart, bad for prostate - Apr 26, 2011
- Heart drug cuts prostate cancer risk - Apr 03, 2011
- Statins can cut prostate cancer risk - Oct 02, 2011
- Exercise improves survival in prostate cancer patients - Feb 02, 2012
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
- How to manipulate 'TRAP' gene for treating cancer - Dec 30, 2009
- Low fat, fish oil diet helps slow down cancer - Oct 26, 2011
- Coffee 'cuts advanced prostate cancer risk' - Dec 08, 2009
- Long-term statin 'unlikely to increase cancer risk' - Nov 10, 2010
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- Exercise 'cuts death risk for men with prostate cancer' - Jan 06, 2011
- Bad cholesterol feeds brain tumours - Sep 16, 2011
- Heavy, daily drinking ups high-grade prostate cancer risk - Jul 13, 2009
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
Tags: account factors, bloomberg school of public health, cancer cells, cancer centre, cancer prevention and control, cancer prevention trial, cell survival, cholesterol level, cholesterol levels, cholesterol lowering drugs, history of prostate cancer, hopkins researchers, johns hopkins bloomberg school of public health, kimmel cancer, low cholesterol, prostate cancer incidence, prostate cancer prevention, prostate cancers, school of public health, signaling pathways